Product image of Latanoprost Viatris (Latanoprost) supplied by GNH India

Latanoprost Viatris

Active Ingredient:
Latanoprost
Origin:
EU

Latanoprost Viatris (Latanoprost)

Latanoprost, the active ingredient in Latanoprost Viatris, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure and is indicated for primary open‑angle glaucoma and ocular hypertension in adult patients. The medication is formulated for once‑daily instillation and is widely used in ophthalmology practice.

GNH India supplies Latanoprost Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across all markets. Our global logistics network supports timely delivery to diverse healthcare settings.

Manufacturer / TM Owner

Viatris Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Latanoprost is a prostaglandin analog that reduces intra‑ocular pressure by enhancing aqueous humor outflow, making it a cornerstone therapy for several glaucoma‑related conditions.

  • Primary open‑angle glaucoma: lowers intra‑ocular pressure, helping to prevent optic nerve damage and visual field loss.
  • Ocular hypertension: reduces elevated eye pressure to levels that decrease the risk of developing glaucoma.
  • Secondary open‑angle glaucoma (including pseudoexfoliative glaucoma): improves outflow and controls pressure when other mechanisms are compromised.

How It Works

  • Latanoprost acts as an agonist at prostaglandin F2α (FP) receptors in the ciliary body. Activation of these receptors remodels the extracellular matrix of the uveoscleral pathway, increasing aqueous humor outflow through this route. The enhanced uveoscleral drainage lowers intra‑ocular pressure, providing therapeutic benefit in glaucoma and ocular hypertension. The effect is sustained with once‑daily dosing, and the drug exhibits minimal systemic absorption.

Side Effects

Latanoprost may cause ocular and peri‑ocular changes, most of which are mild and reversible.

Common Side Effects

  • Eye redness: mild conjunctival hyperemia.
  • Increased eyelash growth: longer, thicker lashes.
  • Darkening of iris color: gradual brownish pigmentation.
  • Eye irritation or foreign‑body sensation.

Serious or Rare Side Effects

  • Uveitis or iritis: intra‑ocular inflammation.
  • Macular edema: swelling of the central retina.

Precautions & Warnings

Before and during treatment, certain precautions should be observed.

  • Measure baseline intra‑ocular pressure: obtain a reading before starting therapy.
  • Monitor iris color changes: assess periodically during treatment.
  • Avoid use in active ocular inflammation: contraindicated in uveitis.
  • Counsel patients on possible eyelash and skin pigmentation changes.
  • Store at room temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Latanoprost may interact with other ocular or systemic agents.

Major Interactions (Avoid)

  • Concurrent use of other prostaglandin analog eye drops: may increase ocular side‑effects.
  • Combination with systemic carbonic anhydrase inhibitors: additive IOP‑lowering effect requires monitoring.
  • Use with ocular beta‑blockers: additive pressure reduction may lead to excessive lowering.

Moderate Interactions (Monitor Closely)

  • Co‑administration with ocular corticosteroids: may diminish prostaglandin efficacy.
  • Wearing contact lenses: may cause deposits; advise removal before instillation.

Frequently Asked Questions

Latanoprost Viatris is prescribed to lower intra‑ocular pressure in adults with primary open‑angle glaucoma or ocular hypertension. By reducing eye pressure, it helps to prevent optic nerve damage and the progression of visual field loss associated with these conditions.

Latanoprost binds to prostaglandin F2α (FP) receptors in the eye’s ciliary body, triggering remodeling of the extracellular matrix in the uveoscleral pathway. This enhances aqueous humor outflow through that route, resulting in a sustained reduction of intra‑ocular pressure.

The prescriber determines the appropriate regimen. Typically, one drop of Latanoprost Viatris is instilled in the affected eye(s) once daily, usually in the evening, unless otherwise directed by the treating ophthalmologist.

The safety of latanoprost in pregnancy and lactation has not been established. It is classified as pregnancy category unknown, and clinicians usually weigh potential benefits against unknown risks before prescribing to pregnant or nursing women.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analog class and primarily increases uveoscleral outflow, whereas timolol is a beta‑blocker that reduces aqueous humor production. Both lower intra‑ocular pressure, but prostaglandin analogs often achieve greater pressure reduction with once‑daily dosing and have a different side‑effect profile.

Store Latanoprost Viatris at room temperature, below 25 °C. Keep the bottle in its original packaging, protect it from light and moisture, and avoid freezing. Do not refrigerate unless the label specifically advises otherwise.

Latanoprost Viatris is administered as an ophthalmic solution. The patient should wash their hands, tilt the head back, pull down the lower eyelid to form a pocket, and place one drop into the conjunctival sac. Close the eye gently and avoid blinking excessively for a few minutes.

Although rare, serious adverse events include uveitis or iritis (intra‑ocular inflammation) and macular edema, which can affect central vision. Patients should report any sudden eye pain, redness, vision changes, or swelling promptly to their eye care professional.

Latanoprost Viatris should be avoided in individuals with active ocular inflammation such as uveitis, those who are hypersensitive to latanoprost or any component of the formulation, and patients with a history of severe ocular allergic reactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Latanoprost

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT